Published: September 06, 2022 21:12:03 | Updated: September 14, 2022 22:01:55
-Reuters file photo
India has approved a recombinant nasal vaccine, developed by Indian multinational biotechnology company Bharat Biotech to combat Covid-19.
The country's Health Minister Mansukh Mandaviya gave the information in a tweet on Tuesday, reports Reuters.
The Indian regulator approved the vaccine for primary immunisation of those aged 18 years and above, for restricted use in emergency situations, Mandaviya added.
Moderna to make milestone payments to US for Covid-19 vaccine
Bird flu situation 'worrying', WHO working with Cambodia
A woman dies every two minutes due to pregnancy or childbirth: UN report
Oral dose of azithromycin at normal birth can reduce 33pc maternal sepsis and deaths: Study
Can topical treatment alone fix acne scars?
Vitamin A-plus campaign for 22.0 million children held
Why the success of making an artificial heart remains elusive?
No specific research on zinc level in rice
© 2024 - All Rights with The Financial Express
